Potent <i>N</i>-(1,3-Thiazol-2-yl)pyridin-2-amine Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors with Excellent Pharmacokinetics and Low Affinity for the hERG Ion ChannelMark T. Bilodeau, George D. Hartman, W. Wayt Gibbs et al.|Journal of Medicinal Chemistry|2004Cited by 60
Sequential Metabolism of AMG 487, a Novel CXCR3 Antagonist, Results in Formation of Quinone Reactive Metabolites That Covalently Modify CYP3A4 Cys239 and Cause Time-Dependent Inhibition of the EnzymeKirk R. Henne, Bradley K. Wong, Thuy Tran et al.|Drug Metabolism and Disposition|2012Cited by 42
Potent 2-[(pyrimidin-4-yl)amine}-1,3-thiazole-5-carbonitrile-based inhibitors of VEGFR-2 (KDR) kinaseJohn T. Sisko, George D. Hartman, Thomas J. Tucker et al.|Bioorganic & Medicinal Chemistry Letters|2005Cited by 35
Bioactivation of a Novel 2-Methylindole-Containing Dual Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type-2 Cells/d-Prostanoid Receptor Antagonist Leads to Mechanism-Based CYP3A Inactivation: Glutathione Adduct Characterization and Prediction of In Vivo Drug-Drug InteractionSimon Wong, Bradley K. Wong, Peter W. Fan et al.|Drug Metabolism and Disposition|2010Cited by 14